Value through Innovation27 July 2016

Clinical Study Results

  • FLOMAX ® - Urination Disorders
    Clinical Study Number 527.49
    Study Indication Urination Disorders
    Product FLOMAX ®
    Generic Name Tamsulosin
    Lab Code
    Clinical Phase I
    Study Title

    Pharmacokinetics, safety, and tolerability of single oral doses (0.1, 0.2, 0.4 and 0.8 mg) of tamsulosin hydrochloride in children with voiding disorders

    Study Document Trial synopsis 527.49 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.